- Home
- GPUS vs ARTL Comparison
GPUS vs ARTL Comparison
Compare GPUS & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- ARTL
- Stock Information
- Founded
- GPUS 1969
- ARTL 2011
- Country
- GPUS United States
- ARTL United States
- Employees
- GPUS N/A
- ARTL N/A
- Industry
- GPUS
- ARTL Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- ARTL Health Care
- Exchange
- GPUS NYSE
- ARTL Nasdaq
- Market Cap
- GPUS 4.1M
- ARTL 3.6M
- IPO Year
- GPUS 1996
- ARTL N/A
- Fundamental
- Price
- GPUS $2.75
- ARTL $1.00
- Analyst Decision
- GPUS
- ARTL Strong Buy
- Analyst Count
- GPUS 0
- ARTL 2
- Target Price
- GPUS N/A
- ARTL $5.50
- AVG Volume (30 Days)
- GPUS 107.5K
- ARTL 29.1K
- Earning Date
- GPUS 04-15-2025
- ARTL 03-03-2025
- Dividend Yield
- GPUS N/A
- ARTL N/A
- EPS Growth
- GPUS N/A
- ARTL N/A
- EPS
- GPUS N/A
- ARTL N/A
- Revenue
- GPUS $139,425,000.00
- ARTL N/A
- Revenue This Year
- GPUS N/A
- ARTL N/A
- Revenue Next Year
- GPUS N/A
- ARTL N/A
- P/E Ratio
- GPUS N/A
- ARTL N/A
- Revenue Growth
- GPUS 3.50
- ARTL N/A
- 52 Week Low
- GPUS $2.62
- ARTL $0.91
- 52 Week High
- GPUS $20.30
- ARTL $1.70
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- ARTL 34.27
- Support Level
- GPUS N/A
- ARTL $0.97
- Resistance Level
- GPUS N/A
- ARTL $1.08
- Average True Range (ATR)
- GPUS 0.00
- ARTL 0.06
- MACD
- GPUS 0.00
- ARTL -0.02
- Stochastic Oscillator
- GPUS 0.00
- ARTL 14.75
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.